GENE ONLINE|News &
Opinion
Blog

Deals
Deals Oncology
China’s Hansoh Teams Up with Middle East Onco-Collaborator
2022-01-02
Deals ATTR amyloidosis
AstraZeneca, Ionis Close $3.5+ Billion Deal for Rare Protein Misfolding Disorder
2021-12-30
China China
Grand Pharma Inks $590+ Million Deal for China Rights to ITM’s Precision Radiopharmaceuticals
2021-12-28
M&A COVID-19
Quidel to Acquire Ortho Clinical for $6 billion to Diversify Diagnostics Portfolio
2021-12-24
M&A Gene Therapy
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
M&A SanofiBispecific AntibodyT-cell Activation
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
Licensing Immuno-oncologyNovartis
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
M&A Digital Healthcare
Oracle Acquires Cerner to Expand Digital Healthcare Management Offerings
2021-12-21
Asia-Pacific CSL LimitedVifor Pharma
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
M&A PfizerUlcerative Colitis
Pfizer to Acquire Arena and its Immuno-Inflammatory Drug for $6.7 Billion
2021-12-14
Funding Digital HealthcareSeries C Funding
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
M&A Thermo Fisher Scientific
Thermo Fisher Bolsters Clinical Research Services with $17.4 Billion Acquisition of PPD
2021-12-10
Funding Multiomics
Freenome Raises $300 Million Series D for Cancer-Detecting Multiomics Platform
2021-12-08
Deals Rare Disease
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Interviews CDMO
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
1 … 24 25 26 27 28 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top